Literature DB >> 20705263

Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale.

Jochen Wöhrle1, Matthias Kochs, Vinzenz Hombach, Nico Merkle.   

Abstract

OBJECTIVES: This study sought to evaluate the prevalence of subclinical myocardial infarctions with cardiovascular magnetic resonance imaging (CMRI) in patients with patent foramen ovale (PFO) after cryptogenic cerebral ischemic events.
BACKGROUND: A thrombotic mass passing a PFO may embolize in cerebral but also in coronary arteries, resulting in both cerebral and myocardial ischemic events. CMRI with late gadolinium enhancement (LGE) analysis is the most sensitive imaging technique to detect small myocardial infarctions.
METHODS: PFO patients (n = 74) with a first cryptogenic cerebral ischemic event without a clinical history for myocardial infarction underwent CMRI and coronary angiography. Right and left ventricular volumes and ejection fractions were measured by CMRI. LGE imaging was performed after administration of gadolinium-diethylenetriaminepentaacetic acid. The presence of atrial septal aneurysm (ASA) was evaluated by transesophageal echocardiography.
RESULTS: LGE was detected in 8 of 74 (10.8%) patients. LGE pattern was transmural or subendocardial. Patients with LGE and those without did not differ in cardiovascular risk factors, type of ischemic event, presence of ASA, right and left ventricular volumes, and ejection fractions. LGE volume was small and comprised only 7.9 +/- 2.4% of left ventricular muscle mass. Coronary artery disease was ruled out in 7 of 8 patients with LGE. There was a trend towards a larger PFO size in patients with LGE compared with patients without LGE (13.2 +/- 4.1 mm vs. 16.0 +/- 2.8 mm, p = 0.06).
CONCLUSIONS: Subclinical myocardial infarctions determined in CMRI were observed in 10.8% of patients with PFO after a first cryptogenic cerebral ischemic event. Our results strengthen the pathophysiologic role of a PFO with paradoxical embolism in patients with cryptogenic cerebral ischemic events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705263     DOI: 10.1016/j.jcmg.2010.05.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  6 in total

1.  A myocardial infarction may disclose patent foramen ovale.

Authors:  Daniela Trabattoni; Tiziana Zaro; Stefano Garducci
Journal:  J Cardiol Cases       Date:  2012-01-30

2.  PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry.

Authors:  Jochen Wöhrle; Bernard Bertrand; Lars Søndergaard; Mark Turner; Werner Scholtz; Réda Ibrahim; François Bourlon
Journal:  Clin Res Cardiol       Date:  2012-04-10       Impact factor: 5.460

Review 3.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

4.  A unique presentation of four thrombotic events at a time.

Authors:  Ali Raza Rajani; Kosar Hussain; Fahad Omar Baslaib; Ghazi Ahmad Radaideh
Journal:  BMJ Case Rep       Date:  2012-11-27

5.  Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019.

Authors:  Carlos V Serrano; Alexandre de M Soeiro; Tatiana C A Torres Leal; Lucas C Godoy; Bruno Biselli; Luiz Akira Hata; Eduardo B Martins; Isabela C K Abud-Manta; Caio A M Tavares; Francisco Akira Malta Cardozo; Múcio Tavares de Oliveira
Journal:  Arq Bras Cardiol       Date:  2019-08-08       Impact factor: 2.000

6.  A Practical Scoring System to Select Optimally Sized Devices for Percutaneous Patent Foramen Ovale Closure.

Authors:  Joseph M Venturini; Elizabeth M Retzer; J Raider Estrada; Anuj Mediratta; Janet Friant; Sandeep Nathan; Jonathan D Paul; John Blair; Roberto M Lang; Atman P Shah
Journal:  J Struct Heart Dis       Date:  2016-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.